PINION JOHN RICHARD (See Remarks) sold 11.8% of their position (14.44K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $607.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2025ACC: 0000950170-25-032785
Officer· See Remarks
Since Mar 2026
+44.54K
Net shares
Net buyer
$609.2K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
59.01K acquired · 14.47K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+14.49K
Price / share
—
Trade value
—
% of position
16.2%
3/1/2025
89.27K→103.76K
Common Stock
Direct
Shares
+18.44K
Price / share
—
Trade value
—
% of position
17.8%
3/1/2025
103.76K→122.20K
Common Stock
Direct
Shares
−14.44K
Price / share
$42.10
Trade value
$607.88K
% of position
11.8%
3/3/2025
122.20K→107.77K
Common Stock
Direct
Shares
−31.00
Price / share
$42.92
Trade value
$1.33K
% of position
0.0%
3/3/2025
108.46K→108.43K
Total
Net shares
+18.47K
Net value
-$609.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | A · Award | +14.49K | — | — | 16.2% | 89.27K | 103.76K |
| Common Stock Direct | 3/1/2025 | A · Award | +18.44K | — | — | 17.8% | 103.76K | 122.20K |
| Common Stock Direct | 3/3/2025 | S · Sale | −14.44K | $42.10 | $607.88K | 11.8% | 122.20K | 107.77K |
| Common Stock Direct | 3/3/2025 | F · Tax Withholding | −31.00 | $42.92 | $1.33K | 0.0% | 108.46K | 108.43K |
| Total | +18.47K | -$609.21K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Commmon Stock
26.07K shares
Shares
+26.07K
Strike price
42.92
Held after
26.07K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Commmon Stock26.07K shares | 3/1/2025 | A · Award | +26.07K | 42.92 | — | 26.07K |